CureVac NV Correlations
| CVAC Stock | USD 3.04 0.02 0.66% |
The current 90-days correlation between CureVac NV and Jeld Wen Holding is 0.12 (i.e., Average diversification). The correlation of CureVac NV is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
CureVac NV Correlation With Market
Average diversification
The correlation between CureVac NV and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding CureVac NV and DJI in the same portfolio, assuming nothing else is changed.
CureVac |
Moving together with CureVac Stock
| 0.65 | A | Agilent Technologies | PairCorr |
| 0.72 | DRTS | Alpha Tau Medical | PairCorr |
| 0.69 | VRAX | Virax Biolabs Group | PairCorr |
| 0.74 | VTGN | VistaGen Therapeutics | PairCorr |
Moving against CureVac Stock
| 0.57 | DVAX | Dynavax Technologies | PairCorr |
| 0.59 | CDTTW | Conduit Pharmaceuticals | PairCorr |
| 0.44 | VNDA | Vanda Pharmaceuticals | PairCorr |
| 0.44 | VRTX | Vertex Pharmaceuticals | PairCorr |
| 0.33 | EDIT | Editas Medicine | PairCorr |
Related Correlations Analysis
| -0.35 | 0.22 | 0.59 | -0.05 | 0.4 | JELD | ||
| -0.35 | -0.05 | -0.1 | 0.53 | 0.17 | VCSA | ||
| 0.22 | -0.05 | 0.25 | -0.04 | 0.23 | WETO | ||
| 0.59 | -0.1 | 0.25 | 0.09 | 0.66 | KALU | ||
| -0.05 | 0.53 | -0.04 | 0.09 | 0.24 | FARO | ||
| 0.4 | 0.17 | 0.23 | 0.66 | 0.24 | ALNT | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between CureVac Stock performing well and CureVac NV Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze CureVac NV's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| JELD | 2.90 | (0.65) | 0.00 | (1.13) | 0.00 | 4.69 | 33.01 | |||
| VCSA | 2.37 | 0.56 | 0.20 | 1.70 | 2.28 | 5.69 | 31.66 | |||
| WETO | 2.53 | (0.29) | 0.00 | (1.05) | 0.00 | 4.44 | 10.00 | |||
| KALU | 1.49 | (0.11) | 0.00 | (0.32) | 0.00 | 3.07 | 9.62 | |||
| FARO | 2.76 | 0.27 | 0.09 | 0.12 | 2.68 | 4.78 | 22.69 | |||
| ALNT | 2.13 | (0.06) | 0.00 | (0.15) | 0.00 | 4.57 | 16.53 |
CureVac NV Corporate Management
| Pierre BSc | CFO MD | Profile | |
| Patrick Baumhof | Senior Technology | Profile | |
| AxelSven Malkomes | Chief Officer | Profile | |
| Ronald Plasterk | Senior Innovation | Profile | |
| Igor MSc | Chief Board | Profile | |
| Antony Blanc | Chief MD | Profile | |
| Sarah Fakih | Vice Relations | Profile |